JPM23: Sage CEO says postpartum depression is no niche, as zuranolone aims to fill gaps in mental healthcare
https://www.fiercebiotech.com/biotech/jpm23-sage-ceo-says-post-partum-depression-no-niche-zuranolone-aims-fill-gaps-depression
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.